The seventh edition of the Palliative Care Formulary (PCF), a Pharmaceutical Press product from the Royal Pharmaceutical Society, is an essential resource for health professionals who care for patients with progressive end-stage disease. Although written primarily with cancer patients in mind, PCF7 contains specific material relating to several other life-limiting diseases e.g. COPD, congestive heart failure, renal and hepatic failure, and Parkinson's disease. PCF7 also includes several Quick Clinical Guides covering key topics in palliative care and designed for everyday use. Grounded in clinical practice, this comprehensive title includes independent information about drugs used in palliative care, highlighting off-label indications or routes, and dealing with the administration of multiple drugs by continuous subcutaneous infusion.

Features: 

- Two new monographs to reflect increasing use in practice, Denosumab and Parecoxib
- Hepatic chapter fully revised by a multidisciplinary working group
- Cannabinoids monograph fully updated and including the 2019 NICE guidance
- Anticoagulants monograph fully updated to include a brand new table with prescribing guidance for Direct Oral Anticoagulants (DOACs)
- Opioid antagonists outside the CNS fully reviewed to reflect the latest products and evidence for use
- Urinary antimuscarinics, a new combined monograph to reflect the increasing use of other drugs in this category

From the reviews of previous editions

‘PCF [is] a core text for the speciality and has no serious rivals.’ Palliative Medicine

‘The information is up to date and prepared with extreme care. This handbook should be available to staff involved with inpatient consultation, inpatient units of care and home visits.’ Journal of Pain and Symptom Management

‘First class. Highly recommended.’ International Association for Hospice and Palliative Care